 CAMBRIDGE, Mass., July 26, 2022 GLOBE NEWSWIRE -- Editas Medicine, Inc. Nasdaq: EDIT, a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, August 3, 2022, at 8:00 a.m. ET to provide financial results and corporate updates for the second quarter of 2022. 